The Health and Environmental Sciences Institute (HESI) held its 2015 Annual Meeting on 9-12 June 2015 at the Westin Georgetown, Washington, DC, USA.
The program booklet for the 2015 Annual Meeting is linked below:
Tab 1 – Agenda
Tab 2 – HESI Assembly
Tab 3 – Emerging Issues Session
Tab 4 – About HESI
Tab 5 – Speaker Bios
Tab 6 – Strategic Planning
Tab 7 – Participants
Annual Meeting Presentations:
HESI Annual Meeting 2015: A Year in Review – HESI Executive Director, Syril D Pettit
HESI Annual Meeting 2015: HESI Cardiovascular Safety Committee: Bridging nonclinical and clinical science for enhanced cardiac safety – Dr. Brian Berridge
HESI Annual Meeting 2015: HESI Genomics Committee: New tools for safety assessment: small RNA biomarkers and an in vivo model for epigenetic effects – Dr. Karol Thompson (FDA)
HESI Annual Meeting 2015: HESI Protein Allergenicity Committee: Practical challenges in biosafety assessment of novel proteins – Dr. Scott McClain (Syngenta Crop Protection)
HESI Annual Meeting 2015: PATC Satellite context talk: Practical challenges in biosafety assessment – Willy K. Tonui, PhD, RBP, Chief Executive Officer, Kenya National Biosafety Authority
HESI Annual Meeting 2015: Investing in Innovation – Dr. Misti Ushio, Harris Group
HESI Annual Meeting 2015: Clean Water, Enhanced Nutrition, Healthier Populations – Syril Pettit, HESI Executive Director
HESI Annual Meeting 2015: Food Security and Ecosystem Services Speaker – Dr. Segenet Kelemu, Director General, African Insect Science for Food and Health (ICIPE).
HESI Annual Meeting 2015: Global Burden of Disease 2013: Environmental and Occupational Risks, – Dr. Theo Vos –Institute for Health Metrics and Evaluation
Emerging Issues Proposals:
Emerging Issues Presentations:
Models / Tests to Assess Stem Cells as Therapeutic Agents. Using Imaging Technology to Evaluate Stem Cell Safety, Mode of Action and Efficacy
Presented by: Dr. Bill Shingleton (GE Healthcare) and Dr. Greg Mullen (Kings College London)
Transforming Exposure Science Through a Strategic Integration of Emerging Technologies and Big Data to Improve Predictive Exposure Capabilities
Presented by: Dr. Rosemary Zaleski (ExxonMobil Biomedical Sciences)
Nonclinical Efficacy and Safety Studies in Support of Neonatal Pediatric Therapeutics Use and Development
Presented by: Dr. Melissa Tassinari (FDA)
Please contact Ms. Cyndi Nobles (cnobles@hesiglobal.org) for additional information.
hesi@hesiglobal.org
Phone: +1-202-659-8404
Fax: +1-202-659-3859
740 15th Street NW, Suite 600
Washington, DC 20005
Sign up for our monthly e-newsletter.